These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation.
    Author: Wilkin JK, Hammond JJ, Kirkendall WM.
    Journal: Arch Dermatol; 1980 Aug; 116(8):902-5. PubMed ID: 6250496.
    Abstract:
    Captopril, an orally active dipeptidyl-carboxypeptidase inhibitor, is a promising new antihypertensive agent. Cutaneous reactions are the most common side effects of this therapy. The data from 15 previous cases and seven new ones are reviewed. The cutaneous eruptions appear to be pharmacologic. In nature, occurring mostly at higher dosage schedules and resolving at lower dosage levels. Historical data, the results of skin tests, and the known pharmacology of captpril suggest that these captopril-induced eruptions may be the result of potentiation of kinin-mediated cutaneous reactions.
    [Abstract] [Full Text] [Related] [New Search]